EX-FILING FEES 4 ny20045797x1_ex107.htm FILING FEES TABLE


Exhibit 107

Calculation of Filing Fee Tables

Form S-3
(Form Type)

Senti Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 
Security
Type
Security Class
Title
Fee
Calculation
Rule
 
Amount
Registered (1)
   
Proposed
Maximum
Offering
Price Per
Unit
   
Maximum
Aggregate
Offering Price
   
Fee Rate
   
Amount of
Registration
Fee
 
Fees to Be Paid
Equity
Common Stock, par value $0.0001 per share
457(c)
   
52,892,500
(2)
   
$
3.28
(3)
 
$
$173,487,400
     
0.00015310
   
$
$26,560.93
 
                                       
 
Total Offering Amounts
             
$
173,487,400
           
$
26,560.93
 
                                                 
 
Total Fee Offsets
             
$
           
$
 
                                                 
 
Net Fee Due
             
$
173,487,400
           
$
26,560.93
 

(1)
Represents the shares of common stock, $0.0001 par value per share (the “Common Stock”), of Senti Biosciences, Inc. (the “Registrant”) that will be offered for resale by the selling stockholders pursuant to the registration statement to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of additional shares of common stock as may be issuable as a result of stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder.
   
(2)
Consists of (i) 21,157,000 shares of Common Stock, issuable upon conversion of 21,157 shares of Series A Convertible Preferred Stock, par value $0.0001 per share, and (ii) 31,735,500 shares of Common Stock issuable upon conversion of warrants to purchase shares of Common Stock.
   
(3)
This estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Registrant’s Common Stock on March 13, 2025, as reported on the Nasdaq Capital Market.